new oral glp 1 agonist Not an April fool's prank! The small molecule GLP-1 receptor agonist, orforglipron, has been approved by the FDA under the trade name, "Foundayo." We discussed the data in a fall 2025 episode Daily Oral GLP-1 Receptor Agonist

If mismanagement of diabetes occurs, an individual may need IV therapy to help stabilize symptoms and the bodys nutrients

Most of bound IgG could be stripped off from old RBC by galactose and RBC stripped from bound IgG were phagocytosed upon addition of anti-Gal

The best hair responders tend to be people in early-to-moderate thinning who pair GHK-Cu with daily scalp care

Suitable for All Skin Types: Gentle enough for daily use without causing dryness or irritation

Reminder All of the above describes compound-level research

Research indicates that this combination yields benefits such as improved deep sleep, reduced triglycerides, visceral adipose tissue, and carotid intima media thickness, enhanced cognition, and overall improved metabolic function